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Abstract 
Purpose: To investigate in vitro the factors affecting microdialysis probe delivery and recovery of 
puerarin .  
Methods: The recovery and delivery of puerarin were tested for extraction efficiency and retro-dialysis 
methods. Factors such as drug concentration, stirring speed, additives and length of membrane were 
studied to determine differences between recovery and delivery.  
Results: It was observed that the delivery of the targeting analyte was different from its recovery. Both 
delivery and recovery of puerarin were independent of the concentration of the drug. Probe delivery 
increased from 62.18 to 67.98 % (p < 0.01), recovery from 59.19 to 78.44 % (p < 0.01), as stirring speed 
was increased from 0 to 800 rpm. The difference between them directly correlated with stirring speed in 
the range 2.99 to 10.46 %. Besides additives, length of membrane also had a strong influence on 
delivery and recovery. Probe delivery in saline containing 10 % each of ethanol and propylene glycol 
declined from 62.18 to 42.12 % (p < 0.01), while recovery increased slightly but insignificantly (p < 
0.01). Both delivery and recovery declined when the length of membrane was reduced.  
Conclusion: The in vitro experiments indicate that it would be incorrect to equate delivery with recovery 
of puerarin in in vivo microdialysis experiments.  
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Microdialysis is a dynamic technique for 
sampling. It has been widely applied in many 
fields in the last half-century and the technique is 
increasingly getting more sophisticated. It is a 
method that has been used for sampling free-
form drug from the blood and extracellular fluid of 
different tissues, like muscles, organs, either in 
animals, human or plants [1]. Owing to the 
selective permeability of semi-permeable 
membranes, there were no bio-macromolecules 
in the collected samples. It is characterized by its 
continuity, real-time when sampling in vivo and 
its easy sample pretreatment.  
 
In microdialysis experiments, targeting 
compounds are removed from the solution 
surrounding the probe by a diffusion gradient 
established via the continuous perfusion of blank 
medium through the probe. Under this non-
equilibrium condition, the concentration in the 
dialysate will always represent a fraction of the 
real concentration outside. The ratio between the 
fraction and the actual concentration outside is 
known as recovery. On the contrary, with the 
perfusion of drug-containing solution through the 
probe, the ratio between fraction diffused to 
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outside and the perfusion concentration is called 
as delivery. 
 
Usually, the real concentration of analyte in 
extracellular fluid (ECF) in vivo experiments can 
be calculated by dividing the sample 
concentration by delivery itself or the internal 
standard added in the perfusion solution [2-5]. 
However, it is only if there were no significant 
differences between delivery and recovery in 
vitro, can the delivery in vivo be considered as 
the recovery of free-form drug in ECF. However, 
microdialysis is a sensitive method. The delivery 
and recovery can be affected by several factors 
[6].  
 
Puerarin is extracted from Pueraria lobata, a 
traditional Chinese medicine. Different 
preparations of puerarin are now being used in 
clinics in China. Unlike compounds with 
hydrophilicity or lipophilicity, it is an isoflavone C-
glycoside with weak hydrophilicity but poor water 
solubility. The aim of this study was to investigate 
the possibility of replacing recovery with delivery 
in vivo using two methods, namely,  extraction 






Puerarin was obtained from National institutes for 
Food and Drug Control (Beijing, China), sodium 
chloride from Beijing Chemical Reagents 
Company (Beijing, China), Methanol (CH3OH) 
and acetic acid (CH3COOH) from Mreda 
technology Inc (USA), High purity water was 





The high performance liquid chromatography 
(HPLC) system used consisted of an Agilent LC-
20AD solvent delivery module, a 10AV UV 
detector module (Agilent). Sample injections 
were made into a G2171BA valve with a 100μl 
injection loop. An injection volume of 20 μl was 
used for all sample analyses. The system was 
operated using Agilen Chem Station B.04.03 
software. A Agilent ZORBAX Eclipse Plus C18 
column (3.5μm, 4.6 x 10 mm, USA) was 
employed. The mobile phase consisted of 
methanol/1 % CH3COOH (24/76, v/v). All HPLC 
mobile phases were filtered through a 50 mm, 
0.22 μm nylon filter (Jinteng Experiment 
Equipment Co, Ltd) prior to use. An isocratic 
elution was employed at a flow rate of 1ml/min. 
All sample analyses were carried out using UV 
detection at 250 nm with a deuterium lamp. The 
analytical method was developed to be linear in 
the range 0.08248 - 8.248 μg/ml (r2 = 0.9999). 





Microdialysis probe with membrane length of 
10mm and 2mm, molecular weight cut-off of 20 
kDa, pumps and syringes (CMA Microdialysis, 
Sweden) were used in this study.  
 
In vitro characterization of microdialysis 
probes 
 
The in vitro probe recovery of Puerarin was 
determined by two methods: extraction efficiency 
method and retrodialysis method. All methods 
were carried out in a stirred vial with different 
stirring speed , solution or perfusate at 37± 0.2 




In the retro-dialysis experiment, a probe was 
placed in a vial with 10 ml saline in it. The 
standard solution of puerarin in saline was 
pumped through the probe at 1.5 μl/min for 2 h. 
Thereafter, 6 samples were collected every 20 
min. The concentration of puerarin in the 
samples and perfusate were determined by 
HPLC method as previously described as 
described above. Delivery (ED), determined by 







  ………………. (1) 
Extraction efficiency method 
  
In the extraction efficiency experiment, a probe 
was placed in a vial with 10 ml standard solution 
of Puerarin while different drug-free solution was 
pumped through the probe at 1.5 μl/min for 2h. 
Thereafter, a total of 6 dialysate samples were 
collected every 20 min. The concentration of 
puerarin in the collected samples and vial were 
determined by HPLC. Recovery (ER) was 









Several samples were excluded because some 
of the inserts in the sample vials might have 
been be contaminated as they appeared pale 
when injected. Analysis of the data was 
performed by SAS8.2 software by Student’s t-
test or ANOVA. Differences were considered 
significant at p < 0.05. 
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Delivery and Recovery 
 
In these experiments, the concentration of 
puerarin was set at 1 μg/ml. The stirring speed 
was maintained at 100 rpm in this experiment. ER 
and ED were 71.60 and 58.67 %, respectively. 
 
There was significant difference (p < 0.01) 
between ED and ER for puerarin, which indicates 
that under certain conditions, substituting retro-
dialysis method for extraction efficiency method 
was not feasible. So, several factors affecting ED 
and ER were studied, in the following 
experiments. 
 
Influence of drug concentration on ED and ER 
 
 In Whitakers experiments [7], the ED of the 
target compound, doxorubicin, was significantly 
higher than ER, which was ascribed to its strong 
absorption to membrane. The probe membrane 
became and remained red in color after perfusion 
also proved its absorption visually. However, 
puerarin is a colorless solution, and so solutions 
with different drug concentration were tested. 
Theoretically, ED or ER at different concentrations 
displayed no differences, if the drug has no 
adsorption properties [8]. The data are shown in 
Table 1. 
 
There were significant differences between ER 
and ED at each concentration. However, for the 
same method, the result of different 
concentrations did not shown significant 
differences.  
 
Probe clearance of puerarin 
 
The concentration of puerarin in the samples 
decreased sharply and was not detectable by the 
time second sample was taken, as shown in Fig 
1. 
 
Influence of stirring speed of probe on ER and 
ED 
 
The delivery and recovery data at each speed 
are depicted in Fig 2. With increase in stirring 
speed, ER or ED rose gradually. The difference 
between delivery and recovery was directly 
related to stirring speed from 2.99 to 10.46 %. 
 
Influence of different solutions on ER and ED 
 
The solubility of puerarin in the first two solutions 
(saline 1 and saline 2 containing 10 % ethanol 
and 10 % propylene (80/10/10, v/v/v)) was 3.36 
and 12.01 mg/ml, respectively. Solubility in the 
third solution (saline 3 containing 5 % HP-β-CD, 
(5/100, w/v)) was > 13.09 mg/ml, probably 
because more drug molecules might be trapped 
by HP-β-CD after treatment by ultrasonic waves 
(Fig 3). 
 
Table 1: Influence of drug concentration to ER and ED 
(mean±SD, n = 5 or 6) 
 















1.07 58.67±3.41 1.06 71.60±1.79* 
2.08 61.27±0.84 2.06 73.31±1.20** 
4.02 58.77±3.53 3.99 71.77±1.46*** 
﹡ER is significantly different from ED at p < 0.01, when the 
concentration is 1μg/ml; ** ER is significantly different from ED 
at p < 0.01, when the concentration is 2μg/ml; *** ER is 
significantly different from ED at p < 0.01, when the 
concentration is 4 μg/ml 
 
 
Fig 1: Probe clearance of puerarin 
 
Due to the trapping property of HP-β-CD, retro-
dialysis method was not used for it. Most of the 
drug may be trapped after agitation when the 
perfusion solution is prepared and this may affect 
its detection directly. In order to minimize the risk 
of trapping by HP-β-CD, the stirring speed in 
these experiments was set at 0 rpm. The results 
are depicted in Fig 3. ED decreased in solution 2 
while ER increased slightly in solutions 2 and 3, 
when compared with saline group. 
 
 
Influence of length of membrane on ER and ED 
 
Both of ED and ER decreased significantly, as 
shown in Fig 4 but the difference should not be 
ignored. 
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Fig 2: Delivery and recovery at various stirring speed. 
■ = Delivery of 0 rpm group; □ = Recovery of 0 rpm 
group;  ▲ = Delivery of 100 rpm group; △ = Revovery 
of 100 rpm group;  ◆ = Delivery of 800 rpm group; ◊ = 
Recovery of 800 rpm group.  Note: Probe recovery 
was significantly different from delivery at p < 0.01 at 
stirring speed of 0, 100 and 800 rpm  
 
Fig 3: Delivery and recovery of puerarin in different 
solutions. ■ = Delivery of Solution 1; □ = Recovery of 
Solution 1; ▲ = Delivery of Solution 2; △ = Recovery 
of Solution 2; ◊ = Recovery of Solution 3. Note: 
Delivery of solution 2 is significantly different from 
delivery of solution 1 at p < 0.01 while recovery of 
solution 3 is significantly different from recovery of 
solution 1 at p < 0.01. 
 
Fig 4: Delivery and recovey of puerarin with different 
length of probe membrane; ■ = Delivery of 10 mm 
membrane; □ = Recovery of 10 mm membrane;▲ = 





In microdialysis experiments, both recovery and 
delivery should be tested at steady state. Due to 
the fact that they are vulnerable to numerous 
factors, great differences are observed [9]. 
 
Whitaker [7] found that the absorption of the 
membrane led to the difference between ED and 
ER. It was not feasible to replace ER with ED 
when adsorption existed. However, the results of 
our absorption experiments showed that the 
difference was irrelevant to adsorption. The 
membrane did not adsorb puerarin.  
 
The viscosity of blood and depth of anesthesia 
may affect the flow velocity of blood of animals in 
vivo experiments. A fast rate may be helpful to 
the diffusion of analyte. So we chose stirring 
speed in vitro to simulate the flow velocity of 
blood in vivo experiments. In the present study, 
the stirring speed exerted a tremendous 
influence on the results. ER or ED rose gradually 
with increase in stirring speed from 0 to 800 rpm, 
which agree with the results of Stenken’s 
experiments [10]. For the retro-dialysis 
experiment, stirring can avoid high local 
concentration, which is helpful to the diffusion of 
analyte. For the extraction efficiency method, the 
fluid boundary layer [11], which affects mass 
transport through the membrane, may be 
reduced by high stirring speed. Besides, a low 
stirring speed may minimize the gap between ER 
and ED. The results indicate that, for some 
compounds, delivery cannot be regarded as 
recovery in in vivo experiment, especially when 
the animals are awake.  
 
Frequently, different additives are added to the 
perfusate in order to increase in vivo recovery of 
targeting compounds. We investigated three 
different solutions. In all of these solutions, there 
were significant differences between ER and ED. 
It is noteworthy that, compared with the saline 
group, ED of solution 2 reduced, while ER 
increased slightly. This also indicates that 
additives in perfusate can increase trecovery, but 
will also enlarge the gap between ER and ED. 
When additives are added to the perfusate 
solution, delivery cannot be considered to be 
equivalent to recovery of the probe in in vivo 
experiments when calculating the real 
concentration of ECF. 
 
Shortening of length of probe membrane may 
also lead to decrease in ER and ED. Here too 
recovery was significantly different from delivery. 
In in vivo microdialysis experiments, the real 
concentration of analyte in ECF can be 
calculated by dividing the sample concentration 
by recovery. However, recovery was obtained in 
this study by in vivo retro-dialysis experiment. 
This method is based on the fact that, under 
certain conditions, ER is equal to ED. In the 
present case, the difference between ER and ED 
cannot be eliminated. Therefore, the actual 
concentration of analyte in vivo cannot be 
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calculated as described above. It is necessary to 
introduce another coefficient k as previously 
suggested [12,13]. CECF can be calculated 
according to Eqs 3 and 4. Alternatively, in vivo 
recovery can be obtained by no-net-flux method 
[14]. 
( ) ( )
( ) ( )
R inviro R invivo


















These results indicate that, ED should not be 
considered as a substitute for ER, especially 
when one needs to know the real concentration 
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